Dr. weiqi wang | Data collection | Young Scientist Award

Shandong First Medical University Affiliated Provincial Hospital | China

Publication Profile

Scopus

Dr. Weiqi Wang: Bio Summary 🌟

Dr. Weiqi Wang is a dedicated physician specializing in Neurology at the Shandong First Medical University Affiliated Provincial Hospital in China. With a robust background in neurology, his research focuses on neurovascular unit injury mechanisms following subarachnoid hemorrhage (SAH). He is currently involved in leading and contributing to cutting-edge studies on therapeutic strategies for neurological disorders, particularly in the context of brain-targeted stem cell therapy and neurodegenerative diseases.

🎓 Education

  • PhD in Neurology – Qingdao University, 2018-2021

  • Master’s in Neurology – Shandong First Medical University, 2015-2018

  • Bachelor’s in Clinical Medicine – Jining Medical University, 2010-2015

đź’Ľ Professional Experience

  • Physician, Department of Neurology – Shandong First Medical University Affiliated Provincial Hospital (July 2021 – Present)

  • Involved in clinical practice while pursuing various research projects centered on brain injury and neurovascular protection mechanisms.

đź“‘ Academic Citations & Key Publications

  • Wang WeiQi, et al. TAT-mGluR1 Attenuation of Neuronal Apoptosis after Subarachnoid Hemorrhage, ACS Chemical Neuroscience, 2019. (Co-first author)

  • Zhang Cheng, et al. Selective mGluR1 Negative Allosteric Modulator Reduces Blood-Brain Barrier Permeability and Cerebral Edema, Translational Stroke Research, 2020. (Co-first author)

  • Wang HongBin, et al. Negative Allosteric Modulator of mGluR1 Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage, ACS Chemical Neuroscience, 2020. (Co-first author)

  • Zhou XiaoYan, et al. TAT-HSP27 Peptide Improves Neurologic Deficits via Reducing Apoptosis, Frontiers in Cellular Neuroscience, 2022. (Co-first author)

  • Hou YaJun, et al. NT157 Inhibits Glioma Cell Proliferation by Upregulating DR5 Expression, Biomedicine & Pharmacotherapy, 2022. (Other author)

🛠️ Technical Skills

  • Expertise in experimental neurobiology techniques, including stem cell therapies, neurovascular unit research, and gene regulation in neurological disorders.

  • Proficient in animal models, biochemical assays, and molecular biology methods.

đź“š Teaching Experience

  • Actively involved in educating medical students and interns in clinical neurology and neurophysiology at Shandong First Medical University, fostering the next generation of healthcare professionals.

🔬 Research Interests

  • Neuroprotection mechanisms in subarachnoid hemorrhage (SAH) and traumatic brain injury.

  • Targeted therapies using stem cell-derived exosomes and signaling pathways, such as mGluR1 and ERK1/2, in treating neurovascular disorders and neurodegenerative diseases.

  • Understanding the molecular and cellular mechanisms behind neuronal apoptosis and recovery after brain injury.

📚 Top Notes Publications 

 TAT-mGluR1 Attenuation of Neuronal Apoptosis through Prevention of MGluR1α Truncation after Experimental Subarachnoid Hemorrhage
  • Authors: Wang WeiQi, Han Ping, Xie RongXia, Yang MingFeng, Zhang Cheng, Mi QiongJie, Sun BaoLiang, Zhang ZongYong
    Journal: ACS Chemical Neuroscience
    Year: 2019
Selective mGluR1 Negative Allosteric Modulator Reduces Blood-Brain Barrier Permeability and Cerebral Edema After Experimental Subarachnoid Hemorrhage
  • Authors: Zhang Cheng, Jiang Ming, Wang WeiQi, Zhao ShiJun, Yin YanXin, Mi QiongJie, Yang MingFeng, Song YuQiang, Sun BaoLiang, Zhang ZongYong
    Journal: Translational Stroke Research
    Year: 2020
 Negative Allosteric Modulator of mGluR1 Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage

  • Authors: Wang HongBin, Wang WeiQi, Wu QingJian, Hou YaJun, Li HanXia, Yang HuiJuan, Yang MingFeng, Sun BaoLiang, Zhang ZongYong
    Journal: ACS Chemical Neuroscience
    Year: 2020

Article: TAT-HSP27 Peptide Improves Neurologic Deficits via Reducing Apoptosis After Experimental Subarachnoid Hemorrhage

  • Authors: Zhou XiaoYan, Sun JingYi, Wang WeiQi, Li ShuXian, Li HanXia, Yang HuiJuan, Yang MingFeng, Yuan Hui, Zhang ZongYong, Sun BaoLiang, Han JinXiang
    Journal: Frontiers in Cellular Neuroscience
    Year: 2022

 NT157 Inhibits Cell Proliferation and Sensitizes Glioma Cells to TRAIL-Induced Apoptosis by Upregulating DR5 Expression

  • Authors: Hou YaJun, Li DaWei, Wang WeiQi, Mao LeiLei, Fu XiaoYan, Sun BaoLiang, Fan CunDong
    Journal: Biomedicine & Pharmacotherapy
    Year: 2022

weiqi wang | Data collection | Young Scientist Award